LEAH FREEMAN: Open Payments
NPI 1205343795 · CONNERSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 93 payments from 20 companies in 2025. Trend: 2023 $825 · 2024 $1,214 · 2025 $1,521
Food & beverage: $1,462Education: $59
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $194 |
| Vanda Pharmaceuticals Inc. | 12 | $188 |
| ABBVIE INC. | 12 | $178 |
| PFIZER INC. | 8 | $159 |
| Axsome Therapeutics, Inc. | 5 | $102 |
| Lilly USA, LLC | 4 | $75 |
| Novo Nordisk Inc | 4 | $66 |
| Amgen Inc. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $43 |
Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, Auvelity, NURTEC ODT, QULIPTA, Veozah.
Industry payments across IN — which companies pay providers there.
